Vitamin D Inhibits Ovarian Cancer Cell Line Proliferation in Combination with Celecoxib and Suppresses Cyclooxygenase-2 Expression

被引:1
|
作者
Thill, Marc [1 ]
Woeste, Alena [2 ]
Reichert, Kathrin [2 ]
Fischer, Dorothea [2 ]
Rody, Achim [2 ]
Friedrich, Michael [3 ]
Koester, Frank [2 ]
机构
[1] Agaples Markus Hosp, Dept Gynecol & Obstet, Frankfurt, Germany
[2] Med Univ Lubeck, Dept Gynecol & Obstet, D-23538 Lubeck, Germany
[3] Helios Hosp Krefeld, Dept Gynecol & Obstet, Krefeld, Germany
关键词
Vitamin D; celecoxib; cyclooxygenase-2; ovarian cancer; PROSTAGLANDIN METABOLIZING ENZYMES; PROSTATE-CANCER; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; BREAST-CANCER; GROWTH-STIMULATION; COX-2; EXPRESSION; GENE-EXPRESSION; FALLOPIAN-TUBE; PHASE-II;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Vitamin D exhibits multiple anti-proliferative and pro-differentiating actions. Prostaglandin(PG)E2 is a tumor-promoting tissue hormone anabolized by cyclooxygenase-2 (COX-2). Recently, a link between the PG and vitamin D metabolism was reported. Materials and Methods: The influence of calcitriol and celecoxib on the proliferation of ovarian cancer cell lines was measured and the impact of calcitriol on the protein and mRNA expression of COX-2 was quantified by western blot and qRT-PCR, respectively. Results: After COX-2 induction with interleukin (IL)-1 beta, 10 mu M celecoxib did not significantly inhibit the proliferation of OVCAR-3 cells, whereas calcitriol showed such an effect; however, the combination of the two substances had an additive influence. After induction by IL-1 mu, calcitriol inhibited the COX-2 protein, as well as its mRNA expression significantly in OVCAR-3 and SKOV-3 cells. Conclusion: These data suggest a correlation between PG and vitamin D metabolism in their anti-tumorigenic activity in ovarian carcinomas.
引用
收藏
页码:1197 / 1203
页数:7
相关论文
共 50 条
  • [41] Oxysterol induces cyclooxygenase-2 expression in a human cholangiocarcinoma cell line.
    Yoon, JH
    Canbay, AE
    Werneburg, NW
    Gores, GJ
    HEPATOLOGY, 2003, 38 (04) : 403A - 403A
  • [42] Vitamin D and docosahexaenoic acid inhibit proliferation of the ovarian cancer cell line OVCAR4
    Mueller, Paul R.
    Kershner, Alexandra J.
    Breitrick, Brooke, I
    Keller, Katharina N.
    Radtke, Rebecca L.
    Patel, Ruchita J.
    Gierach, Kylie
    Arvedson, Jon
    Moyle-Heyrman, Georgette E.
    Pearson, Debra A.
    NUTRITION AND HEALTH, 2023,
  • [43] The inhibitory effect of celecoxib on Lewis lung carcinoma cell line by regulation of cyclooxygenase-2/cytosolic phospholipase A2
    Pan, Yue
    Xiao, Xuan-ang
    Li, Li-jing
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 12 - 13
  • [44] Nuclear factor-κB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells
    Lim, JW
    Kim, H
    Kim, KH
    LABORATORY INVESTIGATION, 2001, 81 (03) : 349 - 360
  • [45] Somatostatin modulates both cyclooxygenase-2 expression and proliferation in human colon cancer cells
    Colucci, R
    Blandizzi, C
    Tanini, M
    Ghisu, N
    Breschi, MC
    Del Tacca, M
    GASTROENTEROLOGY, 2003, 124 (04) : A100 - A100
  • [46] Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
    Chinery, R
    Beauchamp, RD
    Shyr, Y
    Kirkland, SC
    Coffey, RJ
    Morrow, JD
    CANCER RESEARCH, 1998, 58 (11) : 2323 - 2327
  • [47] Myrrh induces the apoptosis and inhibits the proliferation and migration of gastric cancer cells through down-regulating cyclooxygenase-2 expression
    Sun, Mengxue
    Hua, Jie
    Liu, Gaoshuang
    Huang, Peiyun
    Liu, Ningsheng
    He, Xiaopu
    BIOSCIENCE REPORTS, 2020, 40
  • [48] Berberine inhibits cyclooxygenase-2 expression and PGE2 production in colon cancer cells
    Wang, BM
    Cai, SP
    GASTROENTEROLOGY, 2002, 122 (04) : A215 - A215
  • [49] Interferon-α inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro
    Boström, PJ
    Uotila, P
    Rajala, P
    Nurmi, M
    Huhtaniemi, I
    Laato, M
    UROLOGICAL RESEARCH, 2001, 29 (01): : 20 - 24
  • [50] CYCLOOXYGENASE-2 EXPRESSION PATTERN IS NOT DIFFERENT IN TYPE I AND TYPE II OVARIAN CANCER
    Zaborowski, M.
    Magnowska, M.
    Surowiak, P.
    Zabel, M.
    Spaczynski, M.
    Nowak-Markwitz, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)